Trials / Unknown
UnknownNCT03695055
Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma
Maintenance Therapy After Autologous Hematopoietic Stem Cell Transplantation in High-risk Aggressive Lymphoma
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 14 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Relapse after autologous hematopoietic stem cell transplantation (ASCT) is still challenging for high-risk aggressive lymphoma. This study was to investigate the efficacy and safety of maintenance therapy post-ASCT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Maintenance therapy post-HSCT | Rituximab vs DPP/DCEP-G vs observation |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2020-01-01
- Completion
- 2023-01-01
- First posted
- 2018-10-03
- Last updated
- 2018-10-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03695055. Inclusion in this directory is not an endorsement.